Seroprotection after measles vaccination in children with sickle cell anemia receiving hydroxyurea
Alexandra Power-Hays, Abigail Kincaid, Kathyrn E. McElhinney, Teresa S. Latham, Charles T. Quinn, Robert W. Frenck, Russell E. Ware · 2026
Read Seroprotection after measles vaccination in children with sickle cell anemia receiving hydroxyurea by Alexandra Power-Hays, Abigail Kincaid, Kathyrn E. McElhinney, Teresa S. Latham, Charles T. Quinn, Robert W. Frenck, Russell E. Ware (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13594858.txt.
Description
Alexandra Power-Hays and co-authors check measles shield levels after shots in children with sickle cell anemia on a common drug, in a study from two thousand twenty-six. Records came from a past trial of the blood disease. Shield was judged by a set antibody line after each of two doses.
About ninety-four percent were shielded after dose one, and ninety-two percent after dose two. Each added year of age at dose two cut the shield odds. The drug did not blunt the shield, and starting it earlier raised shield odds. Most of these children match the general crowd after shots. Timely shots plus early drug start win. Readers get calm news amid rising measles.
Catalog record
| CREATOR | Alexandra Power-Hays, Abigail Kincaid, Kathyrn E. McElhinney, Teresa S. Latham, Charles T. Quinn, Robert W. Frenck, Russell E. Ware |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |